Explores how human-in-the-loop oversight can move from principle to practice. with a risk-based framework for determining when HITL is required, how the human role should be defined, and what organizational factors influence its effectiveness.
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
ON-DEMAND WEBINARS
New global research shows how sites prepare source documents, where inefficiencies occur, and why workflows differ — highlighting ways to streamline processes, cut delays, and improve data quality.
Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.
In a recent webinar, Sanofi and Flatiron Health leaders shared how a large academic medical center saved time and effort on trial data management using Flatiron Clinical Pipe™.
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1356381571 world data]( "RWD/RWE In 2023: Regulatory Policy World Tour")
RWD/RWE In 2023: Regulatory Policy World TourLearn about what the industry considers RWD/RWE priorities for the year, as well as current efforts being taken within each region around the globe.
-
![Digitalization, machine learning, AI, computer technology-GettyImages-1226549706]( "The Power Of A Collaboration Platform")
The Power Of A Collaboration PlatformUsing a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.
-
Suvoda Products
Suvoda Products Listing.
-
![Virtual doctor patient data]( "Patient Voice Impacts Treatment Experience")
Patient Voice Impacts Treatment ExperienceDownload this guide for five key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.
-
![GettyImages-870849774 EDC medrio]( "Reflexion Counts On Medrio To Launch First Studies")
Reflexion Counts On Medrio To Launch First StudiesLearn how a therapeutic oncology company was able to take advantage of an EDC system, establish a ePRO assessments collections platform, and receive guidance on data collection devices.
-
![Documentation-getty-1349390515]( "Improving Quality And Efficiency In TMF Document Processing")
Improving Quality And Efficiency In TMF Document ProcessingBy adhering to the principles outlined in this article, learn how teams can be better enabled to carry out efficient, high-quality processing of documents throughout the entirety of a study.
-
![GettyImages-1938542776 doctor patient]( "Why Real-Time eCOA Data Matters More Than Ever")
Why Real-Time eCOA Data Matters More Than EverReal-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.
-
![video conference team meeting-GettyImages-2095813137]( "Streamlined Site Study Start-Up")
Streamlined Site Study Start-UpExplore the critical process of Study Start-Up (SSU) in clinical trials, with an emphasis on the collaborative efforts of sponsors and research sites to enhance efficiency and reduce timelines.
-
![GettyImages-1195510533 diverse patients]( "Achieving Person-Centricity In Clinical Trial Recruitment")
Achieving Person-Centricity In Clinical Trial RecruitmentClinical trial enrollment remains a major bottleneck in drug development, but consumer-centric innovations could present a solution to enhance every stage of clinical trial enrollment.
-
![GettyImages-1314466105 breast cancer]( "6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies")
6 Key Ways Real-World Data Is Accelerating Breast Cancer TherapiesReal-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.
RECENT NEWSLETTERS
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
